Xencor (XNCR) FCF Margin (2013 - 2026)

Xencor (XNCR) reported FCF Margin of 1511.03% for Q1 2026, down 145706.0% year-over-year from N/an in Q1 2025, and down 707.31% quarter-over-quarter from 187.17% in Q4 2025.

Xencor (XNCR) FCF Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of FCF Margin data on file, last reported at 1511.03% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 1511.03%, down 145706.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 193.96% (down 6116.0% YoY), and the FY2025 annual result was 110.11%, up 7840.0% from the prior year.
  • FCF Margin slipped to 1511.03% in Q1 2026 per XNCR's latest filing, from 187.17% in the prior quarter.
  • Over five years, FCF Margin peaked at 105.68% in Q2 2022 and troughed at 1511.03% in Q1 2026.
  • A 5-year average of 195.91% and a median of 97.55% in 2024 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2025 and 2026: FCF Margin jumped 30230 bps in 2025, then slumped 145706 bps in 2026.
  • A 5-year view of FCF Margin shows it stood at 159.25% in 2022, then jumped by 121 bps to 33.69% in 2023, then tumbled by 390 bps to 97.55% in 2024, then sank by 92 bps to 187.17% in 2025, then slumped by 707 bps to 1511.03% in 2026.
  • Business Quant data shows XNCR's FCF Margin at 1511.03% in Q1 2026, 187.17% in Q4 2025, and 147.63% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -1,511.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,511.03%
Dec 31, 2025 -187.17%
Sep 30, 2025 -147.63%
Jun 30, 2025 -84.28%
Mar 31, 2025 -53.97%
Dec 31, 2024 -97.55%
Sep 30, 2024 -165.30%
Jun 30, 2024 -294.37%
Mar 31, 2024 -356.26%
Dec 31, 2023 33.69%
Sep 30, 2023 -50.90%
Jun 30, 2023 -92.38%
Mar 31, 2023 -218.32%
Dec 31, 2022 -159.25%
Sep 30, 2022 -55.87%
Jun 30, 2022 105.68%
Mar 31, 2022 4.36%
Dec 31, 2021 36.02%
Sep 30, 2021 -212.20%
Jun 30, 2021 -17.70%